Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MAP1 antibody (AA 337-351)

This Rabbit Polyclonal antibody specifically detects MAP1 in WB. It exhibits reactivity toward Human.
Catalog No. ABIN636277

Quick Overview for MAP1 antibody (AA 337-351) (ABIN636277)

Target

See all MAP1 Antibodies
MAP1 (Mannosidase Processing 1 (MAP1))

Reactivity

  • 6
  • 1
  • 1
Human

Host

  • 6
  • 1
Rabbit

Clonality

  • 6
  • 1
Polyclonal

Conjugate

  • 3
  • 2
  • 2
This MAP1 antibody is un-conjugated

Application

  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Binding Specificity

    AA 337-351

    Purification

    Affinity chromatography purified

    Immunogen

    MAP1 antibody was raised in rabbit using AA 337-351 EEEALLQAILEGNFT of the human MAP-1 protein as the immunogen.

    Isotype

    IgG
  • Application Notes

    WB: 1:500-1:1,000
    Optimal conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    Lot specific

    Buffer

    Affinity purified IgG supplied in PBS with 0.02 % NaN3.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
  • Target

    MAP1 (Mannosidase Processing 1 (MAP1))

    Alternative Name

    MAP1

    Background

    A novel Bax-associating protein, named MAP-1 (Modulator of Apoptosis), mediates caspase-dependent apoptosis in mammalian cells when overexpressed. MAP-1 homodimerizes and associates with the proapoptotic Bax and the prosurvival Bcl-2 and Bcl-X(L) of the Bcl-2 family in vitro and in vivo in mammalian cells.

    Pathways

    Positive Regulation of Endopeptidase Activity
You are here:
Chat with us!